Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India
In Asians, polypoidal choroidal vasculopathy (PCV) is becoming more widely recognized as a significant cause of exudative maculopathy. The previous set of Indian guidelines on the management of PCV were published in 2018, with a literature search updated up to November 2015. As the treatment of PCV...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
| Series: | Indian Journal of Ophthalmology |
| Subjects: | |
| Online Access: | http://www.ijo.in/article.asp?issn=0301-4738;year=2022;volume=70;issue=8;spage=3102;epage=3111;aulast=Sheth |
| _version_ | 1811343824487710720 |
|---|---|
| author | Jay U Sheth Raja Narayanan Giridhar Anantharaman Muna Bhende Aniruddha Agarwal Shobhit Chawla Anand Rajendran |
| author_facet | Jay U Sheth Raja Narayanan Giridhar Anantharaman Muna Bhende Aniruddha Agarwal Shobhit Chawla Anand Rajendran |
| author_sort | Jay U Sheth |
| collection | DOAJ |
| description | In Asians, polypoidal choroidal vasculopathy (PCV) is becoming more widely recognized as a significant cause of exudative maculopathy. The previous set of Indian guidelines on the management of PCV were published in 2018, with a literature search updated up to November 2015. As the treatment of PCV evolves, retinal physicians must constantly modify their current practice. The current guidelines are based on the most up-to-date information on PCV and are an update to the previous set of guidelines. These guidelines were developed by a panel of Indian retinal experts under the aegis of the Vitreoretinal Society of India (VRSI), based on a comprehensive search and assessment of literature up to September 2021. The final guidelines i) provide the updated nomenclature in PCV; ii) discusses the newer diagnostic imaging features of PCV, especially in the absence of indocyanine green angiography (ICGA); and iii) recommends the best possible therapeutic approach in the management of PCV, including the choice of anti-vascular endothelial growth factor (anti-VEGF) agents, treatment regimen, and the role of switching between the anti-VEGF agents. In the face of non-availability of photodynamic therapy (PDT) in India, we constructed practical recommendations on anti-VEGF monotherapy in PCV. The current updated recommendations would provide a broader framework to the treating retinal physician for the diagnosis and management of PCV for optimal therapeutic outcomes. |
| first_indexed | 2024-04-13T19:35:44Z |
| format | Article |
| id | doaj.art-a45f2fdc1a0246aeb6b58e8c345505ed |
| institution | Directory Open Access Journal |
| issn | 0301-4738 1998-3689 |
| language | English |
| last_indexed | 2024-04-13T19:35:44Z |
| publishDate | 2022-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Indian Journal of Ophthalmology |
| spelling | doaj.art-a45f2fdc1a0246aeb6b58e8c345505ed2022-12-22T02:33:02ZengWolters Kluwer Medknow PublicationsIndian Journal of Ophthalmology0301-47381998-36892022-01-017083102311110.4103/ijo.IJO_2985_21Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of IndiaJay U ShethRaja NarayananGiridhar AnantharamanMuna BhendeAniruddha AgarwalShobhit ChawlaAnand RajendranIn Asians, polypoidal choroidal vasculopathy (PCV) is becoming more widely recognized as a significant cause of exudative maculopathy. The previous set of Indian guidelines on the management of PCV were published in 2018, with a literature search updated up to November 2015. As the treatment of PCV evolves, retinal physicians must constantly modify their current practice. The current guidelines are based on the most up-to-date information on PCV and are an update to the previous set of guidelines. These guidelines were developed by a panel of Indian retinal experts under the aegis of the Vitreoretinal Society of India (VRSI), based on a comprehensive search and assessment of literature up to September 2021. The final guidelines i) provide the updated nomenclature in PCV; ii) discusses the newer diagnostic imaging features of PCV, especially in the absence of indocyanine green angiography (ICGA); and iii) recommends the best possible therapeutic approach in the management of PCV, including the choice of anti-vascular endothelial growth factor (anti-VEGF) agents, treatment regimen, and the role of switching between the anti-VEGF agents. In the face of non-availability of photodynamic therapy (PDT) in India, we constructed practical recommendations on anti-VEGF monotherapy in PCV. The current updated recommendations would provide a broader framework to the treating retinal physician for the diagnosis and management of PCV for optimal therapeutic outcomes.http://www.ijo.in/article.asp?issn=0301-4738;year=2022;volume=70;issue=8;spage=3102;epage=3111;aulast=Shethindocyanine green angiographyoptical coherence tomographypolypoidal choroidal vasculopathyvitreoretinal society of india |
| spellingShingle | Jay U Sheth Raja Narayanan Giridhar Anantharaman Muna Bhende Aniruddha Agarwal Shobhit Chawla Anand Rajendran Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India Indian Journal of Ophthalmology indocyanine green angiography optical coherence tomography polypoidal choroidal vasculopathy vitreoretinal society of india |
| title | Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India |
| title_full | Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India |
| title_fullStr | Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India |
| title_full_unstemmed | Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India |
| title_short | Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India |
| title_sort | updated guidelines for the management of polypoidal choroidal vasculopathy recommendations from the indian polypoidal choroidal vasculopathy panel and the vitreoretinal society of india |
| topic | indocyanine green angiography optical coherence tomography polypoidal choroidal vasculopathy vitreoretinal society of india |
| url | http://www.ijo.in/article.asp?issn=0301-4738;year=2022;volume=70;issue=8;spage=3102;epage=3111;aulast=Sheth |
| work_keys_str_mv | AT jayusheth updatedguidelinesforthemanagementofpolypoidalchoroidalvasculopathyrecommendationsfromtheindianpolypoidalchoroidalvasculopathypanelandthevitreoretinalsocietyofindia AT rajanarayanan updatedguidelinesforthemanagementofpolypoidalchoroidalvasculopathyrecommendationsfromtheindianpolypoidalchoroidalvasculopathypanelandthevitreoretinalsocietyofindia AT giridharanantharaman updatedguidelinesforthemanagementofpolypoidalchoroidalvasculopathyrecommendationsfromtheindianpolypoidalchoroidalvasculopathypanelandthevitreoretinalsocietyofindia AT munabhende updatedguidelinesforthemanagementofpolypoidalchoroidalvasculopathyrecommendationsfromtheindianpolypoidalchoroidalvasculopathypanelandthevitreoretinalsocietyofindia AT aniruddhaagarwal updatedguidelinesforthemanagementofpolypoidalchoroidalvasculopathyrecommendationsfromtheindianpolypoidalchoroidalvasculopathypanelandthevitreoretinalsocietyofindia AT shobhitchawla updatedguidelinesforthemanagementofpolypoidalchoroidalvasculopathyrecommendationsfromtheindianpolypoidalchoroidalvasculopathypanelandthevitreoretinalsocietyofindia AT anandrajendran updatedguidelinesforthemanagementofpolypoidalchoroidalvasculopathyrecommendationsfromtheindianpolypoidalchoroidalvasculopathypanelandthevitreoretinalsocietyofindia |